Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.
In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudo...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a517c7331e204bd79a4a62d3101eb19a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a517c7331e204bd79a4a62d3101eb19a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a517c7331e204bd79a4a62d3101eb19a2021-11-18T07:54:38ZLipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane.1932-620310.1371/journal.pone.0057991https://doaj.org/article/a517c7331e204bd79a4a62d3101eb19a2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23483962/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudomonas fluorescens BD5. The aim of this study was to investigate the effect of PFII on A375 melanoma cells compared with the effect of PFII on Normal Human Dermis Fibroblast (NHDF) cells and elucidate the underlying mechanism of PFII cytotoxic activity. Melanoma A375 cells and NHDF cells were exposed to PFII or staurosporine and apoptotic death was assessed by monitoring caspase 3-like activity and DNA fragmentation. From time-dependent monitoring of lactate dehydrogenase (LDH) release, Ca(2+) influx, and a correlation between Critical Micelle Concentration (CMC) we concluded that cell death is the consequence of plasma membrane permeabilisation by micelles. This finding suggests that pro-apoptotic mechanism of PFII is different from previously described cyclic lipopeptides. The mechanism of PFII specificity towards malignant cells remains to be discovered. The results of this study show that PFII could be a new promising anti-melanoma agent.Tomasz JanekAnna KrasowskaAgata RadwańskaMarcin ŁukaszewiczPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e57991 (2013) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Tomasz Janek Anna Krasowska Agata Radwańska Marcin Łukaszewicz Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. |
description |
In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudomonas fluorescens BD5. The aim of this study was to investigate the effect of PFII on A375 melanoma cells compared with the effect of PFII on Normal Human Dermis Fibroblast (NHDF) cells and elucidate the underlying mechanism of PFII cytotoxic activity. Melanoma A375 cells and NHDF cells were exposed to PFII or staurosporine and apoptotic death was assessed by monitoring caspase 3-like activity and DNA fragmentation. From time-dependent monitoring of lactate dehydrogenase (LDH) release, Ca(2+) influx, and a correlation between Critical Micelle Concentration (CMC) we concluded that cell death is the consequence of plasma membrane permeabilisation by micelles. This finding suggests that pro-apoptotic mechanism of PFII is different from previously described cyclic lipopeptides. The mechanism of PFII specificity towards malignant cells remains to be discovered. The results of this study show that PFII could be a new promising anti-melanoma agent. |
format |
article |
author |
Tomasz Janek Anna Krasowska Agata Radwańska Marcin Łukaszewicz |
author_facet |
Tomasz Janek Anna Krasowska Agata Radwańska Marcin Łukaszewicz |
author_sort |
Tomasz Janek |
title |
Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. |
title_short |
Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. |
title_full |
Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. |
title_fullStr |
Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. |
title_full_unstemmed |
Lipopeptide biosurfactant pseudofactin II induced apoptosis of melanoma A 375 cells by specific interaction with the plasma membrane. |
title_sort |
lipopeptide biosurfactant pseudofactin ii induced apoptosis of melanoma a 375 cells by specific interaction with the plasma membrane. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2013 |
url |
https://doaj.org/article/a517c7331e204bd79a4a62d3101eb19a |
work_keys_str_mv |
AT tomaszjanek lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane AT annakrasowska lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane AT agataradwanska lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane AT marcinłukaszewicz lipopeptidebiosurfactantpseudofactiniiinducedapoptosisofmelanomaa375cellsbyspecificinteractionwiththeplasmamembrane |
_version_ |
1718422792130527232 |